DiaSys celebrates 25th anniversary with essential product launches
New enzymatic test for HbA1c
The worldwide rapid rise in diabetes is a challenge for treatment as well as for diagnosis and monitoring. With the new test HbA1c net FS, DiaSys Diagnostics System has introduced an innovative product with highest accuracy setting new standards for reliable results in diagnosing and monitoring diabetes. Based on enzymatic measurement Hba1c net FS ensures highest specificity without interferences by hemoglobin variants as well as outstanding precision. Using the fully automated process including on-board hemolysis on the DiaSys analysers, BioMajesty® and respons®910, labs of every size can optimize their workflow for HbA1c.
Several other major product launches were made in time for DiaSys’ 25th anniversary. Under the trademark QDx DiaSys announced a point-of-care product line comprising test strips and devices for various diagnostic fields such as cardiac, vitamin D, allergy, anemia, lipids and urinalysis. Furthermore, respons®910UP was presented offering improved handling and performance for the small to medium lab (up to 150 tests/hour).
25 years of success as a mid-size company in the challenging and ever changing market of in-vitro diagnostics – DiaSys takes this opportunity to thank all employees, customers and partners for their contribution and confidence and looks forward to a common prospering future.www.diasys-diagnostics.com
